- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 874276, 7 pages
Rhus verniciflua Stokes against Advanced Cancer: A Perspective from the Korean Integrative Cancer Center
1Integrative Cancer Center, East-West Neo Medical Center, Kyung Hee University, 149 Sangil-Dong, Gangdong-Ku Seoul 134-727, Republic of Korea
2Graduate School of East-West Medical Science, Kyung Hee University, Yongin 449-701, Republic of Korea
3Department of Hematology and Oncology, East-West Neo Medical Center, Kyung Hee University, Seoul 134-727, Republic of Korea
Received 29 July 2011; Revised 8 September 2011; Accepted 8 September 2011
Academic Editor: Masa-Aki Shibata
Copyright © 2012 Woncheol Choi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- A. Jemal, E. Ward, Y. Hao, and M. Thun, “Trends in the leading causes of death in the United States, 1970–2002,” Journal of the American Medical Association, vol. 294, no. 10, pp. 1255–1259, 2005.
- H. Beinfield and E. Korngold, “Chinese medicine and cancer care,” Alternative Therapies in Health and Medicine, vol. 9, no. 5, pp. 38–52, 2003.
- A. Gamble, D. Bensky, and T. Kaptchuk, Chinese Herbal Medicine: Materia Medica, Eastland Press, Seattle, Wash, USA, 1993.
- Y. O. Son, K. Y. Lee, J. C. Lee et al., “Selective antiproliferative and apoptotic effects of flavonoids purified from Rhus verniciflua Stokes on normal versus transformed hepatic cell lines,” Toxicology Letters, vol. 155, no. 1, pp. 115–125, 2005.
- H. S. Jang, S. H. Kook, Y. O. Son et al., “Flavonoids purified from Rhus verniciflua Stokes actively inhibit cell growth and induce apoptosis in human osteosarcoma cells,” Biochimica et Biophysica Acta, vol. 1726, no. 3, pp. 309–316, 2005.
- M. Samoszuk, J. Tan, and G. Chorn, “The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts,” BMC Complementary and Alternative Medicine, vol. 5, article 5, 2005.
- J. C. Lee, K. Y. Lee, J. Kim et al., “Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells,” Food and Chemical Toxicology, vol. 42, no. 9, pp. 1383–1388, 2004.
- T. H. Won, P. S. Seo, S. D. Park, D. L. Kim, and J. H. Park, “Clinical features in 147 patients with systemic contact dermatitis due to the ingestion of chicken boiled with Japanease lacquer tree,” Korean Journal of Dermatology, vol. 46, no. 6, pp. 761–768, 2008.
- S. D. Park, S. W. Lee, J. H. Chun, and S. H. Cha, “Clinical features of 31 patients with systemic contact dermatitis due to the ingestion of Rhus (lacquer),” British Journal of Dermatology, vol. 142, no. 5, pp. 937–942, 2000.
- Z. Sminova, W. C. Choi, I. Kubasova, and A. Baryshnikov, “Antitumor efficacy of the allergen-removed extract (ACM909Q) in Rhus verniciflua,” European Journal of Pharmaceutical Sciences, vol. 17, pp. 78–79, 2002.
- W. C. Choi, E. O. Lee, H. J. Lee, et al., “Study on antiangiogenic and antitumor activities of processed Rhus verniciflua Stokes extract,” Korean Journal of Oriental Physiology & Pathology, vol. 20, pp. 825–829, 2006.
- M. H. Jung, S. H. Lee, E. M. Ahn, and Y. M. Lee, “Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway,” Carcinogenesis, vol. 30, no. 4, pp. 655–661, 2009.
- M. Nguyen, J. Arkell, and C. J. Jackson, “Human endothelial gelatinases and angiogenesis,” International Journal of Biochemistry and Cell Biology, vol. 33, no. 10, pp. 960–970, 2001.
- G. Moon, S. H. Lee, and J. H. Park, “Effect of allergen removed Rhus verniciflua extract on inhibition of tumor metastasis,” Journal of Korean Traditional Oncology, vol. 15, no. 1, pp. 47–61, 2010.
- J. S. Kim, B. Y. Park, E. K. Park et al., “Screening of anti-angiogenic activity from plant extracts,” Korean Journal of Pharmacognosy, vol. 37, no. 4, pp. 253–257, 2006.
- S. H. Cheon, K. S. Kim, S. Kim, H. S. Jung, W. C. Choi, and W. K. Eo, “Efficacy and safety of Rhus verniciflua stokes extracts in patients with previously treated advanced non-small cell lung cancer,” Forschende Komplementarmedizin, vol. 18, no. 2, pp. 77–83, 2011.
- S. H. Lee, W. C. Choi, and S. W. Yoon, “Impact of standardized Rhus verniciflua stokes extract as complementary therapy on metastatic colorectal cancer: a Korean single-center experience,” Integrative Cancer Therapies, vol. 8, no. 2, pp. 148–152, 2009.
- H. R. Kim, K. S. Kim, H. S. Jung, W. C. Choi, W. K. Eo, and S. H. Cheon, “A case of recurred hepatocellular carcinoma refractory to doxorubicin after liver transplantation showing response to herbal medicine product, Rhus verniciflua stokes extract,” Integrative Cancer Therapies, vol. 9, no. 1, pp. 100–104, 2010.
- S. H. Lee, W. C. Choi, K. S. Kim, J. W. Park, and S. W. Yoon, “Shrinkage of gastric cancer in an elderly patient who received Rhus verniciflua Stokes extract,” Journal of Alternative and Complementary Medicine, vol. 16, no. 4, pp. 497–500, 2010.
- S. K. Lee, H. S. Jung, W. K. Eo, S. Y. Lee, S. H. Kim, and B. S. Shim, “Rhus verniciflua Stokes extract as a potential option for treatment of metastatic renal cell carcinoma: report of two cases,” Annals of Oncology, vol. 21, no. 6, pp. 1383–1385, 2010.
- S. H. Lee, K. S. Kim, W. C. Choi, and S. W. Yoon, “Successful outcome of advanced pulmonary adenocarcinoma with malignant pleural effusion by the standardized Rhus verniciflua stokes extract: a case study,” Explore, vol. 5, no. 4, pp. 242–244, 2009.
- R. H. Shoemaker, “The NCI60 human tumour cell line anticancer drug screen,” Nature Reviews Cancer, vol. 6, no. 10, pp. 813–823, 2006.
- D. J. Newman and G. M. Cragg, “Natural products as sources of new drugs over the last 25 years,” Journal of Natural Products, vol. 70, no. 3, pp. 461–477, 2007.
- H. W. Hirte, “Novel developments in angiogenesis cancer therapy,” Current Oncology, vol. 16, no. 3, pp. 50–54, 2009.
- D. G. Song, J. Y. Lee, E. H. Lee et al., “Inhibitory effects of polyphenols isolated from Rhus verniciflua on Aldo-keto reductase family 1 B10,” BMB Reports, vol. 43, no. 4, pp. 268–272, 2010.
- J. H. Kim, C. H. Jung, B. H. Jang et al., “Selective cytotoxic effects on human cancer cell lines of phenolic-rich ethyl-acetate fraction from Rhus verniciflua Stokes,” American Journal of Chinese Medicine, vol. 37, no. 3, pp. 609–620, 2009.
- H. Wagner and G. Ulrich-Merzenich, “Synergy research: approaching a new generation of phytopharmaceuticals,” Phytomedicine, vol. 16, no. 2-3, pp. 97–110, 2009.
- D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011.
- F. Azam, S. Mehta, and A. L. Harris, “Mechanisms of resistance to antiangiogenesis therapy,” European Journal of Cancer, vol. 46, no. 8, pp. 1323–1332, 2010.
- E. L. Kwak, Y. J. Bang, D. R. Camidge et al., “Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer,” New England Journal of Medicine, vol. 363, no. 18, pp. 1693–1703, 2010.
- A. M. Jubb, A. J. Oates, S. Holden, and H. Koeppen, “Predicting benefit from anti-angiogenic agents in malignancy,” Nature Reviews Cancer, vol. 6, no. 8, pp. 626–635, 2006.
- G. Deng, H. Lin, A. Seidman et al., “A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects,” Journal of Cancer Research and Clinical Oncology, vol. 135, no. 9, pp. 1215–1221, 2009.
- G. S. Jeong, D. S. Lee, M. Y. Song et al., “Butein from Rhus verniciflua protects pancreatic β cells against cytokine-induced toxicity mediated by inhibition of nitric oxide formation,” Biological and Pharmaceutical Bulletin, vol. 34, no. 1, pp. 97–102, 2011.
- J. D. Lee, J. E. Huh, G. Jeon et al., “Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models,” International Immunopharmacology, vol. 9, no. 3, pp. 268–276, 2009.
- J. Lee and K. T. Lim, “Plant-originated glycoprotein (36 kDa) suppresses interleukin-4 and-10 in bisphenol A-stimulated primary cultured mouse lymphocytes,” Drug and Chemical Toxicology, vol. 33, no. 4, pp. 421–429, 2010.
- L. De Monte, M. Reni, E. Tassi et al., “Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer,” Journal of Experimental Medicine, vol. 208, no. 3, pp. 469–478, 2011.